GI Motility Program

GI motility refers to the progression of food, fluids and waste through the digestive tract. Motility problems include acid reflux, chronic constipation and incontinence.

Cedars-Sinai's GI Motility Program is unique among motility centers because it treats almost all GI motility problems. We focus on the diagnosis and treatment of these digestive tract problems. Our program offers the most advanced diagnosis and treatment methods and is recognized throughout the world for our latest research discoveries, which are already being used to help patients.

Millions of people with irritable bowel syndrome (IBS) now can be diagnosed quickly and accurately with simple blood tests, developed by Mark Pimentel, MD.

Mark Pimentel, MD, executive director of the Cedars-Sinai Medically Associated Science and Technology Program pioneered the use of the drug rifaximin to treat irritable bowel syndrome.

How You Can Help

Support tomorrow’s breakthroughs and a brighter future for IBS patients.

Mark Pimentel, MD
Program Director

Mark Pimentel, MD

"The better we understand this disease, the more tools we will have for fighting it."